Motivational Interviewing (June/July)

Date of Issue: 06/01/2016 | Volume: 4 | Number: 5

Issue Links:Learning Objectives | Editorial Information

Motivational Interviewing (MI) is a technique that helps patients sort through ambivalence about their substance use disorder. In this issue, we give you information on how you can successfully incorporate MI techniques into your practice, including practical advice from David Rosengren, PhD.

In This Issue


Motivational Interviewing: Ten Tips

Topics: Addiction | Practice Tools and Tips | Substance Abuse

Dr. Rosengren presents ten tips for motivational interviewing to help clinicians listen and help their clients struggling with addiction issues.

Read More
Expert Q&A

Using Motivational Interviewing in Your Practice

Topics: Addiction | Cognitive Behavioral Therapy | Substance Abuse

At its most basic, motivational interviewing is a conversation in which you are trying to help someone deal with ambivalence that prevents them from acting on a problematic behavior. At a more complex level, it has to do with things like paying attention to how the patient talks and what kind of language they’re using. In this interview, Dr. Rosengren discusses the language and process of motivational interviewing.

Read More
Research Update

Psychedelic Mushrooms May Help Treatment Resistant Depression

Topics: Depressive Disorder | Research Updates

Psilocybin, a naturally occurring and psychedelic compound of the Psilocybe species of mushrooms, has garnered the most attention. Psilocybin is essentially a serotonin 2A agonist. Theoretically, this action should mediate depressive symptoms, but we don’t know for sure because no available antidepressants are direct agonists of this receptor. Researchers from the United Kingdom set out to see if this is indeed the case.

Read More
Research Update

Good News for Smoking Cessation Drugs: Not as Scary as Once Thought

Topics: Research Updates | Smoking Cessation Agents

Both varenicline (Chantix) and bupropion (Zyban) are effective anti-smoking agents, but over the years we’ve heard about potential neuropsychiatric side effects, especially related to varenicline. These include depression, suicidal thoughts, psychosis, and nightmares.

Read More